OBJECTIVE: The prevalence and workplace consequences of adult attention deficit/hyperactivity disorder (ADHD) are unknown. METHODS: An ADHD screen was included in a national household survey (n = 3198, ages 18-44). Clinical re-interviews calibrated the screen to diagnoses of Diagnostic and Statistical Manual of Mental Disorders, 4th edition ADHD. Diagnoses among workers were compared with responses to the WHO Health and Work Performance Questionnaire (HPQ). RESULTS: A total of 4.2% of workers had ADHD. ADHD was associated with 35.0 days of annual lost work performance, with higher associations among blue collar (55.8 days) than professional (12.2 days), technical (19.8 days), or service (32.6 days) workers. These associations represent 120 million days of annual lost work in the U.S. labor force, equivalent to dollar 19.5 billion lost human capital. CONCLUSIONS: ADHD is a common and costly workplace condition. Effectiveness trials are needed to estimate the region of interest of workplace ADHD screening and treatment programs.
OBJECTIVE: The prevalence and workplace consequences of adult attention deficit/hyperactivity disorder (ADHD) are unknown. METHODS: An ADHD screen was included in a national household survey (n = 3198, ages 18-44). Clinical re-interviews calibrated the screen to diagnoses of Diagnostic and Statistical Manual of Mental Disorders, 4th edition ADHD. Diagnoses among workers were compared with responses to the WHO Health and Work Performance Questionnaire (HPQ). RESULTS: A total of 4.2% of workers had ADHD. ADHD was associated with 35.0 days of annual lost work performance, with higher associations among blue collar (55.8 days) than professional (12.2 days), technical (19.8 days), or service (32.6 days) workers. These associations represent 120 million days of annual lost work in the U.S. labor force, equivalent to dollar 19.5 billion lost human capital. CONCLUSIONS:ADHD is a common and costly workplace condition. Effectiveness trials are needed to estimate the region of interest of workplace ADHD screening and treatment programs.
Authors: Marc Schneider; Wolfgang Retz; Andrew Coogan; Johannes Thome; Michael Rösler Journal: Eur Arch Psychiatry Clin Neurosci Date: 2006-09 Impact factor: 5.270
Authors: Ronald C Kessler; Lenard A Adler; Michael J Gruber; Chaitanya A Sarawate; Thomas Spencer; David L Van Brunt Journal: Int J Methods Psychiatr Res Date: 2007 Impact factor: 4.035
Authors: Kathleen A Hennessey; Michael D Stein; Cynthia Rosengard; Jennifer S Rose; Jennifer G Clarke Journal: J Atten Disord Date: 2009-09-22 Impact factor: 3.256
Authors: Friedrich Wetterling; Hazel McCarthy; Leonardo Tozzi; Norbert Skokauskas; John P O'Doherty; Aisling Mulligan; James Meaney; Andrew J Fagan; Michael Gill; Thomas Frodl Journal: Hum Brain Mapp Date: 2015-08-19 Impact factor: 5.038